S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction

Răzvan Gheorghiţă Mareş, Adrian Horaţiu Sabău, Iuliu Gabriel Cocuz, Mihaela Elena Tomuţ, Istvan Adorjan Szabo, Andreea Raluca Szőke, Andreea Cătălina Tinca, Gabriel Jakobsson, Ovidiu Simion Cotoi, Alexandru Şchiopu

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology